Cargando…
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
Cathepsin S (CTSS) has previously been implicated in a number of cancer types, where it is associated with poor clinical features and outcome. To date, patient outcome in breast cancer has not been examined with respect to this protease. Here, we carried out immunohistochemical (IHC) staining of CTS...
Autores principales: | Wilkinson, Richard D. A., Burden, Roberta E., McDowell, Sara H., McArt, Darragh G., McQuaid, Stephen, Bingham, Victoria, Williams, Rich, Cox, Órla T., O'Connor, Rosemary, McCabe, Nuala, Kennedy, Richard D., Buckley, Niamh E., Scott, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620839/ https://www.ncbi.nlm.nih.gov/pubmed/31346333 http://dx.doi.org/10.1155/2019/3980273 |
Ejemplares similares
-
Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016) -
Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015) -
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
por: Humphries, Matthew P., et al.
Publicado: (2018) -
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
por: Parkes, Eileen E., et al.
Publicado: (2016) -
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
por: Alvi, Muhammad A., et al.
Publicado: (2015)